Schedule 13G ownership disclosure
CM Life Sciences, Inc.
Security class unavailable · CUSIP: 18978W208
Event date: 2020-09-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,465,000
- Percent of class
- 7.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-003294
- Form type
- SC 13G
- Filer
- GeneDx Holdings Corp.
- CIK
- CIK 1818331
- Filed
- Sep 11, 2020
- Reporting period
- Sep 04, 2020
- Description
- Schedule 13G beneficial ownership